Northwest Quadrant Wealth Management, LLC Astrazeneca PLC Transaction History
Northwest Quadrant Wealth Management, LLC
- $439 Million
- Q4 2024
A detailed history of Northwest Quadrant Wealth Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Northwest Quadrant Wealth Management, LLC holds 3,680 shares of AZN stock, worth $285,200. This represents 0.05% of its overall portfolio holdings.
Number of Shares
3,680
Previous 3,681
0.03%
Holding current value
$285,200
Previous $286,000
15.73%
% of portfolio
0.05%
Previous 0.07%
Shares
13 transactions
Others Institutions Holding AZN
# of Institutions
1,366Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.68 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.18 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.91 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.87 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.86 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $240B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...